Apolipoprotéine A1 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Apolipoprotéine A1" in French language version.

refsWebsite

Global rank French rank

485^th place

416^th place

1,626^th place

2,018^th place

4^th place

12^th place

222^nd place

129^th place

4,455^th place

1,915^th place

1tandfonline.com

507^th place

420^th place

low place

low place

1thieme-connect.de

low place

7,214^th place

low place

low place

clinsci.org

Vuilleumier N, Charbonney E, Fontao L et al. Anti‐(apolipoprotein A‐1) IgGs are associated with high levels of oxidized low‐density lipoprotein in acute coronary syndrome, Clin Sci, 2008;115:25–33

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000118137 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000032083 - Ensembl, May 2017

jbc.org

Shao B, Bergt C, Fu X et al. Tyrosine 192 in apolipoprotein A‐I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1‐dependent cholesterol transport, J Biol Chem, 2005;280:5983–93

jlr.org

Petrlova J, Duong T, Cochran MC et al. The fibrillogenic L178H variant of apolipoprotein A‐I forms helical fibrils, J Lipid Res, 2012;53:390–8

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine

oup.com

academic.oup.com

Batuca JR, Ames PR, Amaral M, Favas C, Isenberg DA, Delgado Alves J, Anti‐atherogenic and anti‐inflammatory properties of high‐density lipoprotein are affected by specific antibodies in systemic lupus erythematosus, Rheumatology, 2009;48:26–31
Vuilleumier N, Rossier MF, Pagano S et al. Anti‐apolipoprotein A‐1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction, Eur Heart J, 2010;31:815–23
Montecucco F, Vuilleumier N, Pagano S et al. Anti‐Apolipoprotein A‐1 auto‐antibodies are active mediators of atherosclerotic plaque vulnerability, Eur Heart J, 2011;32:412–21

tandfonline.com

Vuilleumier N, Bratt J, Alizadeh R, Jogestrand T, Hafstrom I, Frostegard J, Anti‐apoA‐1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity, Scand J Rheumatol, 2010;39:447–53

thieme-connect.de

Antiochos P, Marques‐Vidal P, Virzi J et al. Association between anti‐apolipoprotein A‐1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study, Thromb Haemost, 2016;116:764–71

wiley.com

onlinelibrary.wiley.com

Lagerstedt JO, Dalla‐Riva J, Marinkovic G et al. Anti‐ApoA‐I IgG antibodies are not associated with carotid artery disease progression and first‐time cardiovascular events in middle‐aged individuals, J Intern Med, 2018;285:49-58
Haase CL, Frikke‐Schmidt R, Nordestgaard BG et al. Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels, J Intern Med, 2011;270:136–46